symbol-TMAN

TMAN T.Man Pharmaceutical Public Company Limited

TMAN
T.Man Pharmaceutical Public Company Limited
10.40
+0.10 (+0.97%)
High10.60
Low10.30
Total Vol368,500
Total Val(K)3,845.00
Description
Business operations: 1.Manufactures and/or distributes pharmaceutical and healthcare products under the company`s brands 2.Manufactures and/or distributes pharmaceutical and healthcare products under the brands of third parties

Overview


  • SymbolTMAN
  • Market Cap (M.Bath)4,120.04
  • IPO Date22 Oct 2024
  • IPO Price16.30 @Par Value 0.75 Baht
  • CHIEF EXECUTIVE OFFICERMr. PRAPON THANACHOTIPAN
  • Employees-
  • IndustryCONSUMP
  • SectorPERSON
  • IndexsSET
  • SET ESG Ratings-

สรุปภาพรวมตลาด

T.Man Pharmaceutical Public Company Limited
Websitewww.tmanpharmaceutical.com
Address69/1 Soi Bangkhunthian 14, Samaedum, Bangkhunthian Bangkok 10150
Telephone0-2415-1007
Fax0-2416-1241

Detail of Security

MarketSET
First Trade Date22 Oct 2024
IndustryCONSUMP
SectorPERSON
Foreign Limit (%)49.00 (Date 18 Sept 2026)
Foreign Ownership Limit Remaining (shares)195,928,364
Free Float (%)21.36
Par Value0.75
ISIN Number
Local : THC209010006
Foreign : THC209010014
NVDR : THC209010R16
Dividend PolicyThe Company has a policy to pay dividends to shareholders at a rate of not less than 40% of net profit based on the separate financial statements after corporate income tax and after all statutory and other reserves required by law and the Company`s Articles of Association. However, the Board of Directors may consider dividend payments at a rate different from the above, taking into account various factors for the best interest of the Company and/or its shareholders, such as economic conditions, operating results and financial position, cash flows, reserves for future investments, reserves for debt repayment, or working capital requirements, including conditions and restrictions under loan agreements, and provided that such dividend payments do not materially affect the Company`s normal operations, as deemed appropriate by the Board of Directors. In the event that the Company deems it appropriate to pay dividends, such payment shall comply with applicable laws, regulations, rules, notifications, and the Company`s Articles of Association. Annual dividend payments shall be subject to approval by the shareholders` meeting, except for interim dividends, which may be approved by the Board of Directors from time to time when the Company has sufficient profits, and such interim dividend payments shall be reported to the next shareholders` meeting.
Fiscal End31 Dec 2026
The person supervising accountingMiss Arisara Buapli (Start Date 1 Jun 2024)
The person taking the highest responsibility in finance and accountingMiss Darika Taengtrong (Start Date 1 Jun 2022)
Capital Detail
Common Stock
Authorized Capital300,002,700
Paid-up Capital300,002,700
Preferred Shares
Authorized Capital-
Paid-up Capital-
Shares Detail
Common Stock
Listed Shares400,003,600
Paid-up Stock400,003,600Voting Right Ratio 1:1
Treasury Stock - : - - : -
Voting Stock minus Treasury Stock 31 Aug 2026 : 400,003,600 21 Sept 2026 : 400,003,600
Preferred Shares
Listed Shares-
Paid-up Stock-Voting Right Ratio -
Treasury Stock - : - - : -
Voting Stock minus Treasury Stock - : - - : -

Key Issues

Upcoming Event

Mascot efin ไม่มีรายการNo data found

Relate Stock Sectors

Check out other big names from the same Sectors TMAN

symbol-https://s3.efinancethai.com/symbols-logo/TMAN.pngTMAN
efin Focus Metrics
Quarter 2/2026
Z-Score
3.42
3.87
5.21
Monitor C-Score
0.00
0.00
0.00
ICR
32.13
40.45
-601.40
DSCR
0.45
3.86
0.00
EV/EBITDA
7.24
8.57
246,457.00
FCF Yield
18.59
19.51
0.00
FCF/Net Income
2.18
3.11
0.00
Net Debt/EBITDA
0.57
-0.16
0.00
ROIC
25.05
7.25
54.69
Valuation Metrics
Last Price
10.40
29.25
6.00
P/E
20.55
49.54
18.32
P/BV
1.98
1.00
3.99
Dividend Yield
5.14
4.36
8.70
Financial Strength
D/E
0.76
0.29
0.99
Current Ratio
1.56
3.11
1.88
Net Profit Margin
17.28
4.57
17.76
ROE/ROA
1.44
1.03
1.86
Growth Metrics
Revenue Growth YoY
10.99
-12.18
29.51
Revenue Growth 3Y
0.00
-22.65
61.10
Revenue Growth 3Y CAGR
0.00
-8.20
17.23
Revenue per Share
0.00
0.01
0.00
EPS Growth
-8.61
-73.35
91.50
EBITDA Growth
14.85
-30.94
95.95
5Y CAGR Total Return
0.00
4.88
0.46
Market Cap (M.Bath)
4,360.04
4,985.20
3,454.23
Average Volume
4,485.36
49.27
2,464.98

efin Focus Metrics

Quarter 2/2026
Z-Score
Monitor C-Score
ICR
DSCR
EV/EBITDA
FCF Yield
FCF/Net Income
Net Debt/EBITDA
ROIC
Z-Score
xxx
xxx
xxx
Monitor C-Score
xxx
xxx
xxx
ICR
xxx
xxx
xxx
DSCR
xxx
xxx
xxx
EV/EBITDA
xxx
xxx
xxx
FCF Yield
xxx
xxx
xxx
FCF/Net Income
xxx
xxx
xxx
Net Debt/EBITDA
xxx
xxx
xxx
ROIC
xxx
xxx
xxx

Valuation Metrics

Last Price
10.40
29.25
6.00
P/E
20.55
49.54
18.32
P/BV
1.98
1.00
3.99
Dividend Yield
5.14
4.36
8.70

Financial Strength

D/E
0.76
0.29
0.99
Current Ratio
1.56
3.11
1.88
Net Profit Margin
17.28
4.57
17.76
ROE/ROA
1.44
1.03
1.86

Growth Metrics

Revenue Growth YoY
10.99
-12.18
29.51
Revenue Growth 3Y
0.00
-22.65
61.10
Revenue Growth 3Y CAGR
0.00
-8.20
17.23
Revenue per Share
0.00
0.01
0.00
EPS Growth
-8.61
-73.35
91.50
EBITDA Growth
14.85
-30.94
95.95
5Y CAGR Total Return
0.00
4.88
0.46
Market Cap (M.Bath)
4,360.04
4,985.20
3,454.23
Average Volume
4,485.36
49.27
2,464.98
Note
  • Calculated using adjusted prices.
  • Data is shown and calculated based on consolidated financial statements, presented as year-to-date quarterly figures. (If consolidated statements are unavailable, company-only statements are used.)
  • Financial data is updated quarterly within 7 business days after new statements are released.
  • Financial statement data reflects what listed companies submit for each period. Users should review the full financial statements for details, as some companies may revise comparative figures in the latest full version.
  • The list of companies included in the SETESG Index is announced together with other indices, based on the latest SET ESG Ratings results. Source: www.set.or.th (Copyright @ The Stock Exchange of Thailand).